Status:
COMPLETED
Prevalence of Oral Lesions in COVID-19 Patients
Lead Sponsor:
Kafrelsheikh University
Conditions:
Oral Lesions
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
Recently, a new coronavirus disease 2019 (COVID-19) has appeared and caused an unprecedented pandemic which is considered as an urgent threat to health authorities worldwide. Several symptoms are obse...
Eligibility Criteria
Inclusion
- age \> 18 years.
- laboratory-confirmed COVID-19 infection (reverse transcription-polymerase chain reaction, RT-PCR).
Exclusion
- patients without a laboratory-confirmed diagnosis of COVID-19 infection.
- patients with olfactory or gustatory dysfunctions before the epidemic.
- patients with some malignant neoplasms.
- patients with neurodegenerative disorders.
Key Trial Info
Start Date :
September 2 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 10 2021
Estimated Enrollment :
124 Patients enrolled
Trial Details
Trial ID
NCT04917549
Start Date
September 2 2020
End Date
June 10 2021
Last Update
April 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dalia Rasheed Issa
Kafr ash Shaykh, Kafr el-Sheikh Governorate, Egypt, 33511